Research ExplorerScientific StaffAlexander Stein Publications

Alexander Stein

graph of relations
Affiliations
ORCID: 0000-0002-9768-0086
1 - 50 out of 119Page size: 50

Publications

  1. 2024

  2. Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) - a multicenter, randomized, controlled, open-label investigator-initiated trial

    Schmidt, C., Zapf, A., Ozga, A-K., Canbay, A., Denzer, U., De Toni, E. N., Lohse, A. W., Schulze, K., Rösch, T., Stein, A., Wege, H. & von Felden, J., 01.08.2024, In: BMC CANCER. 24, 1, p. 931

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors: The CARE for CAYA Program-A Randomized Clinical Trial Embedded in a Longitudinal Cohort Study

    von Grundherr, J., Elmers, S., Koch, B., Hail, L-A., Mann, J., Escherich, G., Bergelt, C., Samland, L., Jensen, W., Vettorazzi, E., Stark, M., Valentini, L., Baumann, F. T., Singer, S., Reer, R., Beller, R., Calaminus, G., Faber, J., Classen, C. F., Gebauer, J., Hilgendorf, I., Koehler, M., Puzik, A., Salzmann, N., Sander, A., Schiffmann, L., Sokalska-Duhme, M., Schuster, S., Kock-Schoppenhauer, A-K., Bokemeyer, C., Sinn, M., Stein, A., Dwinger, S. & Salchow, J., 04.03.2024, In: JAMA NETW OPEN. 7, 3, p. e242375

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial

    Schmoll, H-J., Mann, J., Meinert, F., Garlipp, B., Borchert, K., Vogel, A., Goekkurt, E., Kaiser, U., Hoeffkes, H-G., Rüssel, J., Kanzler, S., Edelmann, T., Forstbauer, H., Göhler, T., Hannig, C., Hildebrandt, B., Roll, C., Bokemeyer, C., Steighardt, J., Cygon, F., Ibach, S., Stein, A. & Tintelnot, J., 02.2024, In: BRIT J CANCER. 130, 2, p. 233-241 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial

    Thuss-Patience, P., Högner, A., Goekkurt, E., Stahl, M., Kretzschmar, A., Götze, T., Stocker, G., Reichardt, P., Kullmann, F., Pink, D., Bartels, P., Jarosch, A., Hinke, A., Schultheiß, C., Paschold, L., Stein, A. & Binder, M., 02.01.2024, In: JAMA NETW OPEN. 7, 1, p. e2352830

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial

    Seufferlein, T., Lausser, L., Stein, A., Arnold, D., Prager, G., Kasper-Virchow, S., Niedermeier, M., Müller, L., Kubicka, S., König, A., Büchner-Steudel, P., Wille, K., Berger, A. W., Kestler, A. M. R., Kraus, J. M., Werle, S. D., Perkhofer, L., Ettrich, T. J. & Kestler, H. A., 2024, In: PLOS ONE. 19, 6, p. e0304324

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2023

  8. Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy

    Goetze, T. O., Stein, A., Lorenzen, S., Habibzada, T., Goekkurt, E., Herhaus, P., Loose, M., Sookthai, D., Brulin, T., Ihrig, K., Pauligk, C. & Al-Batran, S-E., 15.11.2023, In: INT J CANCER. 153, 10, p. 1726-1733 8 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  9. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

    Rha, S. Y., Oh, D-Y., Yañez, P., Bai, Y., Ryu, M-H., Lee, J., Rivera, F., Alves, G. V., Garrido, M., Shiu, K-K., Fernández, M. G., Li, J., Lowery, M. A., Çil, T., Cruz, F. M., Qin, S., Luo, S., Pan, H., Wainberg, Z. A., Yin, L., Bordia, S., Bhagia, P., Wyrwicz, L. S. & KEYNOTE-859 investigators, 11.2023, In: LANCET ONCOL. 24, 11, p. 1181-1195 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial

    Paschold, L., Stein, A., Thiele, B., Tintelnot, J., Henkes, S-S., Coith, C., Schultheiß, C., Pantel, K., Riethdorf, S. & Binder, M., 06.2023, In: J IMMUNOTHER CANCER. 11, 6, e006678.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

    Subbiah, V., Kreitman, R. J., Wainberg, Z. A., Gazzah, A., Lassen, U., Stein, A., Wen, P. Y., Dietrich, S., de Jonge, M. J. A., Blay, J-Y., Italiano, A., Yonemori, K., Cho, D. C., de Vos, F. Y. F. L., Moreau, P., Fernandez, E. E., Schellens, J. H. M., Zielinski, C. C., Redhu, S., Boran, A., Passos, V. Q., Ilankumaran, P. & Bang, Y-J., 05.2023, In: NAT MED. 29, 5, p. 1103-1112 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia

    Kreitman, R. J., Moreau, P., Ravandi, F., Hutchings, M., Gazzah, A., Michallet, A-S., Wainberg, Z. A., Stein, A., Dietrich, S., de Jonge, M. J. A., Willenbacher, W., De Grève, J., Arons, E., Ilankumaran, P., Burgess, P., Gasal, E. & Subbiah, V., 02.03.2023, In: BLOOD. 141, 9, p. 996-1006 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

    Tintelnot, J., Xu, Y., Lesker, T. R., Schönlein, M., Konczalla, L., Giannou, A. D., Pelczar, P., Kylies, D., Puelles, V. G., Bielecka, A. A., Peschka, M., Cortesi, F., Riecken, K., Jung, M., Amend, L., Bröring, T. S., Trajkovic-Arsic, M., Siveke, J. T., Renné, T., Zhang, D., Boeck, S., Strowig, T., Uzunoglu, F. G., Güngör, C., Stein, A., Izbicki, J. R., Bokemeyer, C., Sinn, M., Kimmelman, A. C., Huber, S. & Gagliani, N., 03.2023, In: NATURE. 615, 7950, p. 168-174 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Adjuvant therapy of biliary tract cancers

    Kefas, J., Bridgewater, J., Vogel, A., Stein, A. & Primrose, J., 2023, In: THER ADV MED ONCOL. 15, p. 17588359231163785

    Research output: SCORING: Contribution to journal › SCORING: Review article › Transfer

  15. Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma

    Artzenroth, J. C., Tintelnot, J., Haag, G. M., Gökkurt, E., Steffens, J. & Stein, A., 2023, In: ONCOL RES TREAT. 46, 7-8, p. 320-325 6 p.

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  16. Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)

    Tintelnot, J., Stein, A., Al-Batran, S-E., Ettrich, T., Götze, T., Grün, B., Haag, G. M., Heuer, V., Hofheinz, R-D., Homann, N., Bröring, T. S., Cruz, M. S., Kurreck, A., Lorenzen, S., Moosmann, N., Müller, C., Schuler, M., Siegler, G., Binder, M. & Gökkurt, E., 2023, In: FRONT ONCOL. 13, p. 1272175

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2022

  18. Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial

    Michnevich, T., Pan, Y., Hendi, A., Oechsle, K., Stein, A. & Nestoriuc, Y., 23.09.2022, In: BMC CANCER. 22, 1, 1008.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial

    Stein, A., Paschold, L., Tintelnot, J., Goekkurt, E., Henkes, S-S., Simnica, D., Schultheiss, C., Willscher, E., Bauer, M., Wickenhauser, C., Thuss-Patience, P., Lorenzen, S., Ettrich, T., Riera-Knorrenschild, J., Jacobasch, L., Kretzschmar, A., Kubicka, S., Al-Batran, S-E., Reinacher-Schick, A., Pink, D., Sinn, M., Lindig, U., Hiegl, W., Hinke, A., Hegewisch-Becker, S. & Binder, M., 01.08.2022, In: JAMA ONCOL. 8, 8, p. 1150-1158 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Immunotherapy in Squamous Cell Cancer of the Esophagus

    Thuss-Patience, P. & Stein, A., 30.03.2022, In: CURR ONCOL. 29, 4, p. 2461-2471 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  21. Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510

    Högner, A., Al-Batran, S-E., Siveke, J. T., Lorenz, M., Bartels, P., Breithaupt, K., Malfertheiner, P., Homann, N., Stein, A., Gläser, D., Tamm, I., Hinke, A., Vogel, A., Thuss-Patience, P. & PaFLO investigators, 15.03.2022, In: INT J CANCER. 150, 6, p. 1007-1017 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial

    Wen, P. Y., Stein, A., van den Bent, M., De Greve, J., Wick, A., de Vos, F. Y. F. L., von Bubnoff, N., van Linde, M. E., Lai, A., Prager, G. W., Campone, M., Fasolo, A., Lopez-Martin, J. A., Kim, T. M., Mason, W. P., Hofheinz, R-D., Blay, J-Y., Cho, D. C., Gazzah, A., Pouessel, D., Yachnin, J., Boran, A., Burgess, P., Ilankumaran, P., Gasal, E. & Subbiah, V., 01.2022, In: LANCET ONCOL. 23, 1, p. 53-64 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer

    Tintelnot, J., Ristow, I., Sauer, M., Simnica, D., Schultheiß, C., Scholz, R., Goekkurt, E., von Wenserski, L., Willscher, E., Paschold, L., Lorenzen, S., Riera-Knorrenschild, J., Depenbusch, R., Ettrich, T. J., Dörfel, S., Al-Batran, S-E., Karthaus, M., Pelzer, U., Hinke, A., Bauer, M., Massa, C., Seliger, B., Wickenhauser, C., Bokemeyer, C., Hegewisch-Becker, S., Binder, M. & Stein, A., 2022, In: FRONT ONCOL. 12, 993611.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2021

  25. Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study

    Bordonaro, R., Calvo, A., Auriemma, A., Hollebecque, A., Rubovszky, G., Saunders, M. P., Pápai, Z., Prager, G., Stein, A., André, T., Argilés, G., Cubillo, A., Dahan, L., Edeline, J., Leger, C., Cattan, V., Fougeray, R., Amellal, N. & Tabernero, J., 10.2021, In: ESMO OPEN. 6, 5, 100270.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data Analysis

    Hempel, L., de Oliveira, J. V., Gaumann, A., Milani, V., Schweneker, K., Schenck, K., Fleischmann, B., Philipp, P., Mederle, S., Garg, A., Piehler, A., Gandorfer, B., Schick, C., Kleespies, A., Sellmann, L., Bartels, M., Goetze, T. O., Stein, A., Goekkurt, E., Pfitzner, L., Robert, S. & Hempel, D., 03.09.2021, In: CANCERS. 13, 17, 4453.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

    Moehler, M., Michel, M., Stein, A., Trojan, J., Marquardt, J., Tintelnot, J., Waidmann, O., Weinmann, A., Woerns, M-A., Schroeder, H., Maenz, M. & Foerster, F., 09.2021, In: FUTURE ONCOL. 17, 25, p. 3309-3319 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. 58/w mit Stiglgangunregelmäßigkeiten und Druckgefühl im rechten Oberbauch

    Stein, A., 16.08.2021, In: ONKOLOGE. 2021, 27, supplement issue 1, p. 129-132

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Education

  29. Effects of a structured counselling-based intervention to improve physical activity behaviour of adolescents and young adult cancer survivors - the randomized phase II Motivate AYA - MAYA trial

    Salchow, J., Koch, B., Mann, J., von Grundherr, J., Elmers, S., Dwinger, S., Escherich, G., Vettorazzi, E., Reer, R., Sinn, M., Baumann, F., Bokemeyer, C., Stein, A. & Jensen, W., 08.2021, In: CLIN REHABIL. 35, 8, p. 1164-1174 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

    Stein, A., Simnica, D., Schultheiß, C., Scholz, R., Tintelnot, J., Gökkurt, E., von Wenserski, L., Willscher, E., Paschold, L., Sauer, M., Lorenzen, S., Riera-Knorrenschild, J., Depenbusch, R., Ettrich, T. J., Dörfel, S., Al-Batran, S-E., Karthaus, M., Pelzer, U., Waberer, L., Hinke, A., Bauer, M., Massa, C., Seliger, B., Wickenhauser, C., Bokemeyer, C., Hegewisch-Becker, S. & Binder, M., 07.2021, In: J IMMUNOTHER CANCER. 9, 7, e002844.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Reply to P. Potemski and K. Bujko

    Schmoll, H-J., Mauer, M. E., Marreaud, S. & Stein, A., 10.04.2021, In: J CLIN ONCOL. 39, 11, p. 1306-1308 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  32. Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial

    Schmoll, H-J., Lindner, L. H., Reichardt, P., Heißner, K., Kopp, H-G., Kessler, T., Mayer-Steinacker, R., Rüssel, J., Egerer, G., Crysandt, M., Kasper, B., Niederwieser, D., Kunitz, A., Eigendorff, E., Petersen, I., Steighardt, J., Cygon, F., Meinert, F. & Stein, A., 01.02.2021, In: JAMA ONCOL. 7, 2, p. 255-262 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP

    Folprecht, G., Trautmann, K., Stein, A., Huebner, G., Stahl, M., Kasper, S., Kretzschmar, A., Köhne, C-H., Grünwald, V., Hofheinz, R-D., Schütte, K., Löffler, H., Bokemeyer, C., Krämer, A. & Arbeitsgemeinschaft Internistische Onkologie (AIO) - CUP Group, 02.2021, In: BRIT J CANCER. 124, 4, p. 721-727 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

    Schmoll, H-J., Stein, A., Van Cutsem, E., Price, T., Hofheinz, R. D., Nordlinger, B., Daisne, J-F., Janssens, J., Brenner, B., Reinel, H., Hollerbach, S., Caca, K., Fauth, F., Hannig, C. V., Zalcberg, J., Tebbutt, N., Mauer, M. E., Marreaud, S., Lutz, M. P. & Haustermans, K., 01.01.2021, In: J CLIN ONCOL. 39, 1, p. 17-29 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Long-Term Follow-Up Guidelines and Organization of Long-Term Follow-Up Care for Children and Young Adult Cancer Survivers

    Langer, T., Beck, J. D., Stein, A., Bokemeyer, C. & Gebauer, J., 2021, Late Treatment Effects and Cancer Survivor Care in the Young: From Childhood to Early Adulthood. Beck, J. D., Bokemeyer, C. & Langer, T. (eds.). 1 ed. Cham: Springer Nature Switzerland, p. 435-439 5 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  36. Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors

    Hilgendorf, I., Bergelt, C., Bokemeyer, C., Kaatsch, P., Seifart, U., Stein, A. & Langer, T., 2021, In: ONCOL RES TREAT. 44, 4, p. 184-189 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  37. 2020

  38. Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays

    Rothkamm, K., Christiansen, S., Rieckmann, T., Horn, M., Frenzel, T., Brinker, A., Schumacher, U., Stein, A., Petersen, C. & Burdak-Rothkamm, S., 28.11.2020, In: CANCER LETT. 493, p. 179-188 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19

    Malsy, J., Veletzky, L., Heide, J., Hennigs, A., Gil-Ibanez, I., Stein, A., Lütgehetmann, M., Rosien, U., Jasper, D., Peine, S., Hiller, J., Haag, F., Schmiedel, S., Huber, S., Jordan, S., Addo, M. M. & Schulze Zur Wiesch, J., 26.10.2020, In: CLIN INFECT DIS. 73, 11, p. e4020–e4024

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study

    Grünwald, V., Karch, A., Schuler, M., Schöffski, P., Kopp, H-G., Bauer, S., Kasper, B., Lindner, L. H., Chemnitz, J-M., Crysandt, M., Stein, A., Steffen, B., Richter, S., Egerer, G., Ivanyi, P., Zimmermann, S., Liu, X. & Kunitz, A., 20.10.2020, In: J CLIN ONCOL. 38, 30, p. 3555-3564 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. IL22BP Mediates the Anti-Tumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans

    Kempski, J., Giannou, A. D., Riecken, K., Zhao, L., Steglich, B., Lücke, J., Garcia-Perez, L., Karstens, K-F., Wöstemeier, A., Nawrocki, M., Pelczar, P., Witkowski, M., Nilsson, S., Konczalla, L., Shiri, A. M., Kempska, J., Wahib, R., Brockmann, L., Huber, P., Gnirck, A-C., Turner, J-E., Zazara, D. E., Arck, P. C., Stein, A., Simon, R., Daubmann, A., Meiners, J., Perez, D., Strowig, T., Koni, P., Kruglov, A. A., Sauter, G., Izbicki, J. R., Guse, A. H., Roesch, T., Lohse, A. W., Flavell, R. A., Gagliani, N. & Huber, S., 10.2020, In: GASTROENTEROLOGY. 159, 4, p. 1417-1430.e3

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

    Subbiah, V., Lassen, U., Élez, E., Italiano, A., Curigliano, G., Javle, M., de Braud, F., Prager, G. W., Greil, R., Stein, A., Fasolo, A., Schellens, J. H. M., Wen, P. Y., Viele, K., Boran, A. D., Gasal, E., Burgess, P., Ilankumaran, P. & Wainberg, Z. A., 09.2020, In: LANCET ONCOL. 21, 9, p. 1234-1243 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

    Cremolini, C., Antoniotti, C., Stein, A., Bendell, J., Gruenberger, T., Rossini, D., Masi, G., Ongaro, E., Hurwitz, H., Falcone, A., Schmoll, H-J. & Di Maio, M., 20.08.2020, In: J CLIN ONCOL. p. JCO2001225

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL

    Nilsson, S., Stein, A., Rolfo, C., Kranich, A., Mann, J., Papadimitriou, K., Theile, S., Amberg, S. & Bokemeyer, C., 27.06.2020, In: CURR CANCER DRUG TAR. 20, 10, p. 811-817 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)

    Tintelnot, J., Goekkurt, E., Binder, M., Thuss-Patience, P., Lorenzen, S., Knorrenschild, J. R., Kretzschmar, A., Ettrich, T., Lindig, U., Jacobasch, L., Pink, D., Al-Batran, S-E., Hinke, A., Hegewisch-Becker, S., Nilsson, S., Bokemeyer, C. & Stein, A., 01.06.2020, In: BMC CANCER. 20, 1, p. 503

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Current status of immunotherapy in gastrointestinal malignancies

    Lorenzen, S., Lordick, F., Loosen, S. H., Tacke, F., Trautwein, C., Roderburg, C., Ettrich, T. J., Perkhofer, L., Reinacher-Schick, A. & Stein, A., 06.2020, In: Z GASTROENTEROL. 58, 6, p. 542-555 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen

    Attenberger, U., Rödel, C., Ghadimi, M., Piso, P., Arnold, D., Folprecht, G., Geissler, M., Hegewisch-Becker, S., Heinemann, V., Kasper, S., Modest, D., Reinacher-Schick, A., Seufferlein, T., Stein, A., Stintzing, S. & Hofheinz, R-D., 06.2020, In: Z GASTROENTEROL. 58, 6, p. 577-582 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Education › peer-review

  48. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family

    Niemeyer, E., Mofid, H., Zornig, C., Burandt, E-C., Stein, A., Block, A. & Volk, A. E., 03.05.2020, In: BMC GASTROENTEROL. 20, 1, p. 129

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Gallengangs- und Gallenblasenkarzinome: auf dem Weg zur personalisierten Therapie

    Sinn, M., Wege, H. & Stein, A., 04.2020, In: DEUT MED WOCHENSCHR. 145, 7, p. 442-446 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work

    Gebauer, J., Baust, K., Bardi, E., Grabow, D., Stein, A., van der Pal, H. J., Calaminus, G. & Langer, T., 13.01.2020, In: ONCOL RES TREAT. 43, 3, p. 61-69 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Education

  51. Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review

    Salchow, J., Mann, J., Koch, B., von Grundherr, J., Jensen, W., Elmers, S., Straub, L. A., Vettorazzi, E., Escherich, G., Rutkowski, S., Dwinger, S., Bergelt, C., Sokalska-Duhme, M., Bielack, S., Calaminus, G., Baust, K., Classen, C. F., Rössig, C., Faber, J., Faller, H., Hilgendorf, I., Gebauer, J., Langer, T., Metzler, M., Schuster, S., Niemeyer, C., Puzik, A., Reinhardt, D., Dirksen, U., Sander, A., Köhler, M., Habermann, J. K., Bokemeyer, C. & Stein, A., 06.01.2020, In: BMC CANCER. 20, 1, p. 16

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  52. Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors

    Simnica, D., Ittrich, H., Bockemeyer, C., Stein, A. & Binder, M., 2020, In: FRONT ONCOL. 10, p. 540030

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. 2019

  54. Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches

    Tintelnot, J. & Stein, A., 07.08.2019, In: WORLD J GASTROENTERO. 25, 29, p. 3920-3928 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  55. Impact of taste and smell training on taste disorders during chemotherapy – TASTE trial

    von Grundherr, J., Koch, B., Grimm, D., Salchow, J., Valentini, L., Hummel, T., Bokemeyer, C., Stein, A. & Mann, J., 16.05.2019, In: CANCER MANAG RES. 11, p. 4493—4504 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling

    Tintelnot, J., Metz, S., Trentmann, M., Oberle, A., von Wenserski, L., Schultheiß, C., Braig, F., Kriegs, M., Fehse, B., Riecken, K., Bokemeyer, C., Stein, A. & Binder, M., 2019, In: FRONT ONCOL. 9, p. 1559

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next